Workshop on biosimilars

EventCorporateBiosimilars

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

Kuupäev

Neljapäev, 31 oktoober 2013, All day

Asukoht

European Medicines Agency, Amsterdam, the Netherlands

The workshop is intended to discuss the draft guideline on similar biological medical products, the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues, and the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: quality issues. Registration closed.

Documents

Agenda - Workshop on biosimilars

Reference Number: EMA/473908/2013

English (EN) (74.69 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

List of participants - Workshop on biosimilars

Reference Number: EMA/681299/2013

English (EN) (143.9 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Draft revised guideline on similar biological medicinal products: Relevant changes (Martina Weise)

English (EN) (234.06 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - EBG’s comments on the draft revised guideline on similar biological medicinal products (Karl Heinz Emmert)

English (EN) (1.09 MB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Guideline on similar biological medicinal products: Overarching guideline

English (EN) (734.59 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Guideline on similar biological medicinal products containing biotechnologically-derived proteins as active substances: quality issues (Niklas Ekman)

English (EN) (159.22 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - EGA’s perspective on the draft quality guideline (Joerg Windisch)

English (EN) (922.36 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substances: Quality issues

English (EN) (656.89 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (Niklas Ekman)

English (EN) (309.73 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues (Hans-Karl Heim)

English (EN) (117.28 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Guideline on Similar biological medicinal products containing biotechnology-derived proteins as active substance: Non-clinical and clinical issues (Pekka Kurki)

English (EN) (360.9 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - EBG’s perspective on the draft guideline on the non-clinical/clinical issues (Mark McCamish)

English (EN) (1.18 MB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Presentation - Nonclinical and clinical considerations

English (EN) (571.74 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Multimedia

Share this page